22.418 articles found

Upregulation of cellular glutathione by 3H-1,2-dithiole-3-thione as a possible treatment strategy for protecting against acrolein-induced neurocytotoxicity.

Jia Z, Misra BR, Zhu H, Li Y, Misra HP.

Neurotoxicology · 2008-11-27

DOI: 10.1016/j.neuro.2008.11.007PMID: 19073213

Sonolysis of levodopa and paracetamol in aqueous solutions.

Isariebel QP, Carine JL, Ulises-Javier JH, Anne-Marie W, Henri D.

Ultrason Sonochem · 2008-11-27

DOI: 10.1016/j.ultsonch.2008.11.008PMID: 19128999

A COMPOSITION CONTAINING CINNAMOMUM CASSIA EXTRACTS, ITS FRACTIONS OR TRANS-CINNAMALDEHYDE AS AN ACTIVE INGREDIENT ISOLATED FROM CINNAMOMUM CASSIA FOR THE PREVENTION AND TREATMENT OF PARKINSON DISEASE

LIM SABINA, KIM YONG SIK, PYO JI HI, JEONG MI YOUNG.

· 2008-11-24

Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.

Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN, NNIPPS Study Group.

Brain · 2008-11-23

DOI: 10.1093/brain/awn291PMID: 19029129

Effect of levodopa and entacapone treatment on plasma homocysteine levels in Parkinson's disease patients.

Nevrly M, Kanovsky P, Vranova H, Langova K, Hlustik P.

Parkinsonism Relat Disord · 2008-11-22

DOI: 10.1016/j.parkreldis.2008.10.005PMID: 19028438

Successful catheter ablation to accessory atrioventricular pathway as cardiac resynchronization therapy in a patient with dilated cardiomyopathy.

Iwasaku T, Hirooka K, Taniguchi T, Hamano G, Utsunomiya Y, Nakagawa A, Koide M, Ishizu T, Yamato M, Sasaki N, Yamamoto H, Kawaguchi Y, Mizuno H, Koretsune Y, Kusuoka H, Yasumura Y.

Europace · 2008-11-20

DOI: 10.1093/europace/eun318PMID: 19028709

Valvular heart disease in patients with Parkinson's disease treated with pergolide, levodopa or both.

Ozer F, Tiras R, Cetin S, Ozturk O, Aydemir T, Ozben S, Meral H, Kizkin S, Bader H, Ozben B.

J Clin Neurosci · 2008-11-17

DOI: 10.1016/j.jocn.2008.02.005PMID: 19014887

Acute stepwise challenge test with levodopa in treated patients with parkinsonism.

Feng T, Li W, Lu L, Wang Y, Shi W, Zhang J, Wang Y, Chan P.

Parkinsonism Relat Disord · 2008-11-14

DOI: 10.1016/j.parkreldis.2008.08.010PMID: 19010079

Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases.

Adhihetty PJ, Beal MF.

Neuromolecular Med · 2008-11-13

DOI: 10.1007/s12017-008-8053-yPMID: 19005780

COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE

SNOW ALAN D, NGUYEN BETH P, CASTILLO GERARDO M, SANDERS VIRGINIA J, LAKE THOMAS P, LARSEN LESLEY, WEAVERS REX T, LORIMER DAVID S, LARSEN DAVID S, COFFEN DAVID L, COFFEN CHARLOTTE, LORIMER STEPHEN D.

· 2008-11-11

Sertraline in the treatment of depressive disorders in patients with Parkinson's disease.

Marino S, Sessa E, Di Lorenzo G, Digangi G, Alagna A, Bramanti P, Di Bella P.

Neurol Sci · 2008-11-11

DOI: 10.1007/s10072-008-1021-3PMID: 19002650

Use of 14-3-3- Proteins in Treatment and Prevention of Neurodegeneration

YACOUBIAN TALENE ALENE, STANDAERT DAVID G.

· 2008-11-07